Abstract
In many cell types, transfer of Ca2+ released via ryanodine receptors (RyR) to the mitochondrial matrix is locally supported by high [Ca2+] microdomains at close contacts between the sarcoplasmic reticulum (SR) and mitochondria. Here we studied whether the close contacts were secured via direct physical coupling in cardiac muscle using isolated rat heart mitochondria (RHMs). “Immuno-organelle chemistry” revealed RyR2 and calsequestrin-positive SR particles associated with mitochondria in both crude and Percoll-purified “heavy” mitochondrial fractions (cRHM and pRHM), to a smaller extent in the latter one. Mitochondria-associated vesicles were also visualized by electron microscopy in the RHMs. Western blot analysis detected greatly reduced presence of SR markers (calsequestrin, SERCA2a, and phospholamban) in pRHM, suggesting that the mitochondria-associated particles represented a small subfraction of the SR. Fluorescence calcium imaging in rhod2-loaded cRHM revealed mitochondrial matrix [Ca2+] ([Ca2+]m) responses to caffeine-induced Ca2+ release that were prevented when thapsigargin was added to predeplete the SR or by mitochondrial Ca2+ uptake inhibitors. Importantly, caffeine failed to increase [Ca2+] in the large volume of the incubation medium, suggesting that local Ca2+ transfer between the SR particles and mitochondria mediated the [Ca2+]m signal. Despite the substantially reduced SR presence, pRHM still displayed a caffeine-induced [Ca2+]m rise comparable with the one recorded in cRHM. Thus, a relatively small fraction of the total SR is physically coupled and transfers Ca2+ locally to the mitochondria in cardiac muscle. The transferred Ca2+ stimulates dehydrogenase activity and affects mitochondrial membrane permeabilization, indicating the broad significance of the physical coupling in mitochondrial function.
Activation of Ca2+-sensitive matrix dehydrogenases by mitochondrial calcium signals represents a common means for rapid tuning of the oxidative ATP production to the varying demand posed by the biological responses to cytosolic [Ca2+] signals ranging from cell differentiation and secretion to muscle contraction (1–3). [Ca2+]m signals evoked by inositol 1,4,5-trisphosphate receptor-dependent Ca2+ release are usually supported locally by high [Ca2+] microdomains at close contacts between the ER2 and mitochondria (Refs. 4 and 5; reviewed in Refs. 6 and 7). We have recently demonstrated that the local Ca2+ coupling is regulated by the spacing between the ER and outer mitochondrial membrane and that the ER-mitochondrial interface is secured by protein tethers (8). Local [Ca2+] regulation has also been shown to support the Ca2+ signal propagation from the ryanodine receptors (RyR, the phylogenetic ancestors of the inositol 1,4,5-trisphosphate receptor) to the mitochondria in cardiac muscle cells (9, 10) and in skeletal muscle (11–13). However, whether the local Ca2+ communication between the SR and mitochondria is supported by physical coupling is yet to be elucidated. Very recently, Protasi and co-workers (14, 15) have visualized tethering structures between SR and mitochondria in electron micrographs and tomographs of skeletal muscle, although those data did not examine the involvement of the tethers in the Ca2+ communication between the organelles. A local metabolic triangle between the sarcomere, SR, and mitochondria that could be dissociated by limited proteolysis in permeabilized cardiomyocytes has also been described earlier (16). Here, we studied the preservation of the SR-mitochondrial associations and local Ca2+ coupling between RyR and mitochondria by visualization of individual organelles and monitoring their function in mitochondria isolated from rat heart homogenates.
MATERIALS AND METHODS
Chemicals/Immunochemicals
Fluorescent probes and fluorescently labeled secondary antibodies were from Molecular Probes (Eugene, OR), except the Ca2+ probes fura2 (K+ salt) and rhod2 acetoxymethylester (rhod2/AM), which were purchased from Teflabs (Austin, TX). Primary antibodies were obtained as follows: mouse monoclonal: anti-RyR2 from ABR (MA3–916), anti-phospholamban from Abcam (ab2865), and anti-cytochrome oxidase subunit 1 from Molecular Probes (A6403); rabbit polyclonal: anti-RyR2 from Chemicon (AB9080), anti-SERCA2 from ABR (MA3–919), anti-VDAC from ABR (PA1–954A), and anti-calsequestrin from Upstate (catalog number 06-382). Other chemicals were from Fisher or Sigma-Aldrich.
Preparation of Membrane Fractions from Rat Heart Homogenate
Isolation Buffer—Isolation buffer was 225 mm mannitol, 75 mm sucrose, 0.1% bovine serum albumin, 10 mm Hepes/Tris, 100 μm EGTA/Tris, pH 7.4.
Mito Storage Buffer—Mito storage buffer was isolation buffer supplemented with 2 mm MgATP and phosphocreatine/creatine phosphokinase (5 μm/5 units/ml).
SR Storage Buffer—SR storage buffer was 250 mm sucrose, 20 mm Tris/HCl, pH 7.0. All of the procedures were done at 4 °C. Male Sprague-Dailey rat(s) (350–400 g) were sacrificed by pentobarbital (75 mg) injection. The heart(s) were immediately removed and minced in isolation buffer with enhanced Ca2+ chelation (containing 500 μm EGTA/Tris). After elimination of visually distinguishable nonventricular parts (large blood vessels, thin atrial wall fragments), the pieces were washed three times into regular isolation buffer and then homogenized in ∼8× volume/volume using a Dounce glass/Teflon homogenizer (∼30 strokes at 1300 rpm). The homogenate was centrifuged at 500 × g for 10 min to sediment unbroken tissue parts and nuclei. The 500 × g supernatant was filtered through a 100-μm nylon sieve (Falcon Cell Strainer) and centrifuged at 8,500 × g for 10 min. The resulting pellet was called the crude mitochondrial fraction (cRHM) and was resuspended in mito storage buffer at ∼20–25 mg/ml final protein concentration if no further purification was desired.
Percoll Purification—For Percoll purification 400 mg of mannitol + 250 mg of sucrose was dissolved in 20 ml of isolation buffer, and 17.5 ml of this solution was mixed with 10 ml of Percoll in a 30-ml centrifuge tube. cRHM pellet was resuspended in ∼1–2 ml of isolation buffer, and 90% of this suspension was transferred to the Percoll mix in the 30-ml centrifuge tube and in turn spun at 50,000 × g for 40 min. The resulting mitochondrial bands (lower/darker “heavy mito” or pRHM and the upper “light mito” or pRHM-light; see Fig. 1) were carefully separated and washed with isolation buffer (30 ml each) by centrifugation at 12,000 × g for 10 min twice. After washing, the pellets were resuspended in mito storage buffer (∼20–25 mg/ml protein). To obtain SR fraction (RHSR), the 8,500 × g supernatant was centrifuged at 40,000 × g for 45 min. The pellet was taken up in SR storage buffer, aliquoted, and stored on ice under N2 until use.
Preparation for Microscopy
30 μl of mitochondrial suspension was transferred to a Cell-Tak™-coated (BD Biosciences, Bedford, MA) round glass coverslip (25-mm diameter) mounted to the bottom of a silicon incubation chamber designed for the microscope stage heater (Harvard Apparatus, Holliston, MA) and incubated for 10–25 min at 37 °C in a humidified enclosure. For fluorescence [Ca2+]m imaging mitochondria were loaded with 4 μm rhod2/AM during the attachment period, in the presence of 0.003% Pluronic F-127 (Molecular Probes).
Immuno-organelle Chemistry
For immuno-organelle chemistry samples were fixed after the attachment period in 4% paraformaldehyde (10 min, room temperature), washed with phosphate-buffered saline, and labeled with primary and secondary antibodies (the latter ones as fluorescent conjugates) according to standard immunocytochemistry protocols. For blocking nonspecific binding of the applied antibodies, the samples were pretreated with either 8% bovine serum albumin in phosphate-buffered saline (for mouse monoclonal primary antibodies, where the secondary antibodies were from rabbit) or 10% goat serum in phosphate-buffered saline (for rabbit polyclonal antibodies, where the secondary antibodies were from goat), according to the suggestions of Affinity Bioreagents. To assess nonspecific binding of secondary antibodies, negative controls with no primary antibodies were used. Apparently, blocking the nonspecific binding was more effective in the case of the polyclonal primary antibodies, perhaps because the serum of the same species (goat) from which the secondary antibody derived was used. As shown in Fig. 2, negative control images were homogenous black in the case of the polyclonal primary antibodies, whereas in the case of the monoclonal ones (pRHM and cRHM), some bright labeling always occurred in the negative control images too, although their relative frequency (to the number of mitochondria) was much smaller than in the samples treated with the primary monoclonal antibodies. Fluorescent DNA probes (green fluorescent YO-PRO1 0.5–1 μm iodide and far-red fluorescent SYTO™ 63 10 μm) used as mitochondrial counter staining were applied during the attachment period for 12–15 min. Western blotting was carried out using a Bio-Rad system according to standard protocols and using pre-cast gels from Bio-Rad.
Fluorescence Wide Field Imaging
Fluorescence wide field imaging of [Ca2+] was carried out using high quantum efficiency cooled CCD cameras attached to Olympus or Leica inverted epifluorescence microscopes fitted with the appropriate excitation/emission filter and beam splitter combinations (from Chroma Technology, Rockingham, VT) for simultaneous recordings of fura2 and rhodamine (rhod2, tetramethyl rhodamine ethyl ester (TMRE)) or fluorescein (YO-PRO1 iodide) fluorescence.
The imaging systems were controlled by a custom-designed software (Spectralyzer). Following the loading/attachment period, the samples were extensively washed into a virtually Ca2+-free (treated with Chelex 100 Resin, sodium form from Bio-Rad) intracellular buffer (ICM; 120 mm KCl, 10 mm NaCl, 1 mm KH2PO4, 20 mm Hepes/Tris, (M.W. 35–45 kDa) 5% dextrane, pH 7.2) supplemented with protease inhibitors (1 μg/ml each antipain, leupeptin, and pepstatin), MgATP 2 mm and phosphocreatine 5 mM/creatine phosphokinase 5 U/ml. The image sequences were usually collected using 40× oil objectives to 14 μm/pixel or 24 μm/pixel CCD chips (384 × 288 or 512 × 512 pixels field size) with no binning or two-bin resolution.
[Ca2+] in the cytosol surrogate intracellular buffer ([Ca2+]c) in the imaging experiments was calibrated by sequential addition of saturating CaCl2 (1.5 mm) and EGTA/Tris, pH 8.7 (10 mm) and then translated to nMs using the Grynkiewicz formula: [Ca2+] (nm) = Kd × (R − Rmin) × Sf2/(Rmax − R) × Sb2(17).
NAD(P)H (auto) fluorescence was recorded without loading any other fluorophores to avoid possible cross-talk to the weak signal. At the end of the recording, either the reducing equivalents in the mitochondrial matrix were brought to a fully reduced state by the electron transport chain complex I inhibitor rotenone (2 μm) (bringing NAD(P)H fluorescence to the maximum) or an uncoupler (5 μm FCCP) was added to bring the reducing equivalents to the fully oxidized state (minimum fluorescence) (see Fig. 8). A small fraction of the mitochondria did not show Ca2+-related NAD(P)H response at all, even though they responded to rotenone and FCCP (not shown). These mitochondria were excluded from the evaluation of the Ca2+-dependent responses.
Confocal Imaging
Confocal imaging of immunofluorescence was carried out using a Bio-Rad Radiance 2100 system connected to an Olympus IX70 inverted microscope. The adherent particles were imaged via a 60 × oil objective with a numeric aperture of 1.45. The scanned field was 512 × 512 pixels. The variable confocal aperture (with a range of 0.8–12 mm) was set to 4 mm, which is wider than the theoretical optimum (1.5 mm) for maximum confocality, but we needed to do this compromise to obtain sufficient fluorescent signal. On the other hand, considering a single layer of organelles attached to the coverglass and that the average diameter of the organelles is close to (mitochondria) or less than (SR) the axial resolution of the lens (1.1 and 1.3 μm at 488- and 568-nm excitation, respectively), calculation errors because of out of focus light are less likely. The axial resolution was calculated from the formula Rax = 2λ/n(sin2θ), where λ is the wavelength of the light, n is the refractive index of the immersion medium, and θ is the semi-angle of the included cone (sinθ = numeric aperture/n).
Image Analysis
Most of the collected wide field and confocal images and image sequences were analyzed using the Spectralyzer software. To determine the mean diameter of the SR (anti-RyR2-labeled) and mitochondria (labeled by DNA probe) in the confocal images the Image J (National Institutes of Health) software was used. For the SR after smoothing, areas with particles of relatively similar intensities were selected, threshold masks were drawn to cover the particles, and then the average Feret’s diameters for the masks was determined. Because the staining of mitochondria with the DNA probes was not sufficiently homogenous for thresholding, the individual particles were masked manually. Because of the nonoptimal confocality as discussed above, the calculated size measures should be considered as rough estimates.
Negative Staining of Mitochondria for Transmission Electron Microscopy
On a 400 mesh copper electron microscopy grid with a carbon-coated Formvar support film (Electron Microscopy Sciences, Hatfield, PA), a drop of cRHM or pRHM suspensions was mixed with bacitracin at 25–50 μg/ml final concentration and with either 4% ammonium-molybdate or 2% potassium-phosphotungstate. Bacitracin was used to enhance the hydrophilicity of the grid to promote better attachment of the membrane particles. After 1 min the mix was blotted away using the edge of a filter paper wedge followed by two additional 1-min washings with the molybdate or potassium-phosphotungstate solution. After washing, the grids were allowed to air dry and kept in a desiccator until the electron microscopy. The negatively stained samples were examined and imaged in a Tecnai 12 transmission electron microscope fitted with a high resolution CCD camera (Hamamastu ORCA-HR).
The data are represented as the means ± S.E. unless specified otherwise and have been collected from at least two to five independent experiments. In the case of fluorescence imaging of adherent membrane particles, one data point used for statistic evaluation represents a mean value of 30–200 individual particles or groups of particles on the imaged field from a single recording, unless it is specified otherwise.
RESULTS
Retention of SR Vesicles in Mitochondrial Fractions of Rat Heart Homogenate—Crude and Percoll-purified mitochondria (cRHM 8,500–12,000 × g pellet and pRHM, respectively; see diagram in Fig. 1) were isolated from rat heart homogenate to determine whether fragments of the relatively light SR (usually sedimented at ∼40,000 × g (18–20)) were copurified with the mitochondria, resisting the extensive separation forces. In the cRHM fraction, Western blot analysis revealed protein bands corresponding to the SR-resident calsequestrin (CSQ) and SERCA along with the outer mitochondrial membrane protein VDAC (Fig. 1). Conversely, pRHM showed hardly detectable SR marker proteins but displayed a strong band labeled with an anti-VDAC antibody (Fig. 1).
Transmission electron micrographs of negatively stained (using ammonium-molybdate or phosphotungstic acid) pRHM or cRHM revealed relatively small membrane vesicles closely associated (10–50-nm gap) with mitochondria, which were consistent in their appearance with SR fragments attached to the outer mitochondrial membrane (supplemental Fig. S1). Immunostaining of adherent membrane particles (immuno-organelle chemistry) detected RyR2-positive (Fig. 2, both polyclonal and monoclonal antibodies) and CSQ-positive (Fig. 3) structures in association with the mitochondria (visualized by fluorescent DNA stains YO-PRO1 iodide and SYTO 63) in both cRHM and pRHM. However, the RyR2- and CSQ-positive SR particles were fewer (2.9 ± 0.3 versus 5.1 ± 0.2 polyclonal anti-RyR2-positive particles/mitochondria counted in three 21 × 21-μm fields) and somewhat fainter in pRHM (Figs. 2 and 3). In parallel, an SR-enriched fraction of the heart homogenate was also prepared that showed intense RyR and CSQ immunostaining but no distinct labeling of membrane particles with the DNA probe (Figs. 2 and 3). The mitochondria were roughly four times larger on average than the particles displaying SR markers (diameter, 1.58 ± 0.04 μm n = 99 versus 0.46 ± 0.04 μm n = 52 in cRHM and 1.88 ± 0.06 μm n = 77 versus 0.48 ± 0.01 μm n = 42 in pRHM).
In the cRHM, the RyR- or CSQ-positive SR particles frequently appeared in contact with the mitochondria visualized by DNA stains (Figs. 2 and 3). Colocalization of numerous CSQ-positive particles with larger structures positively labeled with anti-cytochrome c oxidase antibodies was also observed in cRHM (supplemental Fig. S2). However, association of the SR particles with the mitochondria was even more striking in pRHM (Figs. 2 and 3 and supplemental Fig. S3). Essentially, every SR particle showed the overlap with a mitochondrion (supplemental Fig. S3). Thus, SR fragments were present in both cRHM and pRHM in close association with mitochondria. The presence of mitochondria-associated SR in the pRHM suggested that the SR vesicles were physically coupled to heart mitochondria. Notably, the immunofluorescence approach showed more SR present in the pRHM than was detected by Western blot. This discrepancy between the two methods might be because the cRHM contained more SR fragments not connected to the mitochondria that settled slower to the attachment surface and got washed away at the end of the attachment period. After Percoll purification of cRHM, most of these non-mitochondria-associated SR fragments presumably moved to pRHM-light (Fig. 1).
Adherent Mitochondria Preserve Their Membrane Integrity—cRHM and pRHM attached to CellTak™-coated coverglasses and energized by succinate readily accumulated the potentiometric dye, TMRE (Fig. 4). Upon the addition of an uncoupler, FCCP, TMRE was rapidly released (Fig. 4). The spatial distribution of the TMRE uptake was similar to the distribution of the DNA staining (Fig. 4), confirming the mitochondrial localization. Thus, isolated rat heart membrane particles attached to coverglass represent a suitable model system to study functionally the individual mitochondria.
Preservation of SR Ca2+ Uptake, RyR-dependent Ca2+ Mobilization, and SR-Mitochondrial Local Ca2+ Coupling in cRHM—Incubation of cRHM with rhod2/AM resulted in rhod2 compartmentalization in the mitochondrial particles (Fig. 5A). Compartmentalized rhod2 allowed monitoring of [Ca2+]m in the individual particles. Stimulation with saturating caffeine (10 mm, added together with 5–10 μm thapsigargin to suppress Ca2+ reuptake to the SR) evoked [Ca2+]m rises of varying magnitude in the adherent mitochondria (Fig. 5B, traces represent individual particles). Elevation of the medium [Ca2+] by the addition of 10 μm CaCl2 (raising [Ca2+]c to ∼3 μm) caused a large further increase in [Ca2+]m (Fig. 5B). Dissipation of the driving force of mitochondrial Ca2+ uptake attained by the addition of the protonophore FCCP (2 μm) prevented the caffeine- and Tg-induced rise in the rhod2 fluorescence (94 ± 4% reduction of the peak [Ca2+]m increase; n = 5, not shown). Ru360 (10 μm), a specific inhibitor of the mitochondrial Ca2+ uniporter (MCU) also inhibited the [Ca2+]m rise detected upon caffeine stimulation (85 ± 6% inhibition on the peak [Ca2+]m increase, means ± S.D., n = 2), confirming further the mitochondrial location of the dye and that the [Ca2+]m response was a consequence of the activation of the MCU (Fig. 6, right panel). Thapsigargin pretreatment (5–10 μm Tg for 10–20 min) to predeplete of Ca2+ the SR vesicles retained in the mitochondrial fraction suppressed the caffeine-induced [Ca2+]m rise (Fig. 5C, 60 ± 11% inhibition, means ± S.E., n = 6), suggesting that the caffeine effect was principally caused by RyR2-mediated Ca2+ release from the SR. Interestingly, under the present conditions 10 μm thapsigargin caused only partial inhibition of the SR 45Ca uptake (not shown), in line with the results of Feher (20) in rat heart homogenates. When [Ca2+] in the extravesicular bath medium ([Ca2+]c) was simultaneously recorded with [Ca2+]m, it showed no increase upon caffeine stimulation, suggesting that the mitochondrial Ca2+ uptake was activated by a local rather than global [Ca2+]c change (Fig. 6, left panel). Collectively, these results show that the SR retained in the cRHM preserved its Ca2+-accumulating and -releasing function, as well as its ability to support mitochondrial Ca2+ uptake via a local Ca2+ transfer from RyR-dependent Ca2+ release to the mitochondria. Because Ru360 inhibits only the MCU but not the RyR (21), it was unlikely that the [Ca2+]m rise was mediated by a recently proposed mitochondrial RyR (22).
Local Ca2+ Communication between SR and Mitochondria in pRHM—Mitochondria in rhod2-loaded adherent pRHM (and pRHM-light; not shown) displayed [Ca2+]m rises evoked by caffeine stimulation, comparable with those recorded in cRHM (Fig. 7A, left panel). These signals were also inhibited by Ru360 (76 ± 3% inhibition, n = 5), confirming the primary role of the MCU in the Ca2+ uptake mechanism mediating the recorded [Ca2+]m signal (Fig. 7A, right panel). To ensure optimal Ca2+ loading of the SR, in the beginning of these recordings, a small CaCl2 pulse (0.5–1 μm) was added. This initial CaCl2 pulse, which raised [Ca2+]c to ∼400–800 nm, frequently caused by itself a small [Ca2+]m rise. By contrast, the [Ca2+]m response evoked by the addition of caffeine and Tg appeared without a rise in [Ca2+]c (Fig. 7A), and it persisted even when [Ca2+]c was clamped by 50 μm EGTA at ∼600 nm prior to the caffeine stimulation (Fig. 7B), suggesting that the [Ca2+]m response was activated by a high [Ca2+] microdomain.
The data above shows that RyR-mediated Ca2+ release from small, biochemically hardly detectable “SR appendices” connected to the mitochondria in pRHM locally supports the [Ca2+]m signal activation. This suggests that a small subdomain of the SR physically coupled to the mitochondria bears particular relevance in mitochondrial calcium signaling in cardiac muscle (see scheme in Fig. 10). Notably, the Ca2+ uptake by the mitochondria may utilize an interplay between the local SR Ca2+ source and the global [Ca2+]c signal. Elevation of the global [Ca2+]c may sensitize the MCU to the Ca2+ provided by the local SR Ca2+ store, and vice versa the local [Ca2+]c rise may sensitize the mitochondrial Ca2+ uptake from a global [Ca2+]c signal (23, 24). Indeed, the most effective caffeine-induced Ca2+ transfer to the mitochondria was observed when the [Ca2+]c was elevated by the small Ca2+ prepulse (Fig. 7). Thus, the global [Ca2+]c may also have a contribution in the mitochondrial Ca2+ uptake during Ca2+ release from the mitochondrion-coupled SR Ca2+ store.
NAD(P)H Increase Associated with Caffeine Stimulation in pRHM—[Ca2+]m regulates the activity of the Ca2+-sensitive mitochondrial dehydrogenases, the activity of which can be monitored fluorometrically through changes in the redox state of their pyridine nucleotide cofactors (1–3, 25, 26). To evaluate whether the [Ca2+]m signal evoked by RyR-dependent Ca2+ release in pRHM was sufficient to stimulate the oxidative metabolism, NAD(P)H autofluorescence was monitored during stimulation of pRHM with caffeine and Tg (Fig. 8). An increase in the NAD(P)H fluorescence followed the caffeine stimulation (see the difference image showing the fluorescence increase in blue and the time course traces in Fig. 8) in most of the mitochondrial areas that responded to the uncoupling agent FCCP (by a drop in fluorescence to the minimum, Fig. 8A) or to the electron transport chain complex I inhibitor rotenone (by a fluorescence increase to the maximum; Fig. 8B). Interestingly, the CaCl2 pulse (20 μm) following the caffeine stimulation caused only modest or no further increase in the NAD(P)H fluorescence (Fig. 8), although it evoked a substantial additional [Ca2+]m rise (Fig. 7A), suggesting that the Ca2+-responsive NAD(P)H generation was close to saturation. There was notable heterogeneity in the NAD(P)H responses to caffeine stimulation, and in some instances mitochondria displayed a response even to the preloading Ca2+ pulse (Fig. 8).
These data show that the [Ca2+]m signal driven by the mitochondria-associated SR is competent to stimulate the oxidative metabolism that is a means to enhance mitochondrial ATP production (27). The available room for Ca2+ regulation of the oxidative metabolism can be maximally utilized by the [Ca2+]m signals generated upon caffeine stimulation, further supporting the possible physiological relevance of the “resilient” SR-mitochondrial complexes in the pRHM.
Progressive Mitochondrial Depolarization Following Caffeine Stimulation in pRHM—In the cell, Ca2+ mobilization via RyRs is important for the stimulation of mitochondrial energy metabolism but may also induce mitochondrial membrane permeabilization and release of apoptosis-inducing factors to the cytoplasm if some stress factors (reactive oxygen species, ceramide) are also present or the Ca2+ release is augmented (Refs. 28, 29; see also Ref. 30 for review). However, it remains elusive whether Ca2+ release from the mitochondria-associated SR particles is sufficient to evoke mitochondrial membrane permeabilization. RyR-dependent mitochondrial Ca2+ uptake causes a small and transient mitochondrial depolarization (10, 31), whereas the Ca2+-induced membrane permeabilization leads to progressive loss of the ΔΨm(28). When TMRE-loaded pRHM were exposed to a similar stimulation protocol that we used for the characterization of the caffeine-induced [Ca2+]m and NAD(P)H responses, caffeine stimulation prompted a biphasic decrease in ΔΨm, with a faster initial drop (23 ± 7% in 2 min, from three recordings) followed by a slow continuous decay (42 ± 5% decrease in 8 min after correction to time control; see time course and bar chart in Fig. 9). Notably, the progressive delayed depolarization was evoked by a short lasting Ca2+ release event. The decay in ΔΨm caused by caffeine stimulation was sensitive to cyclosporine A (2 μm, not shown), suggesting involvement of the permeability transition pore opening.
Thus, the mitochondria-bound SR vesicles can provide a trigger for both Ca2+-mediated stimulation of ATP production and permeability transition pore opening. Membrane permeabilization by the small and short lasting Ca2+ release could be promoted by the stress represented by the isolation and storage of the pRHM.
DISCUSSION
The present work reveals associations between SR and mitochondria in the rat heart, which are highly resistant to purification of the mitochondria, indicating the presence of a direct SR-mitochondrial physical coupling. By imaging single isolated mitochondria, we show that the mitochondria-bound SR vesicles preserve their ability to store and release Ca2+ via the ryanodine receptors to locally activate generation of [Ca2+]m signals and in turn to stimulate oxidative metabolism. Furthermore, the present evidence shows that the mitochondria-associated SR vesicles can provide sufficient Ca2+ trigger for induction of mitochondrial membrane permeabilization, which is of relevance for engaging a main cell death pathway. To our knowledge, these results are the first evidence for the presence of direct SR-mitochondrial linkage in the heart and for the relevance of this coupling in mitochondrial metabolism and a possible role in mitochondrial injury.
Percoll purification of cRHM greatly reduced the presence of SR proteins according to the Western blot analysis; however, mitochondria-associated SR vesicles still could be detected by immuno-organelle chemistry. Furthermore, the SR vesicles associated with the pRHM mitochondria were able to locally activate [Ca2+]m signals via RyR2-dependent (caffeine-stimulated) Ca2+ release. Thus, the SR subdomains relevant in the local Ca2+ coupling with the mitochondria apparently represent a relatively small fraction of the total SR that is physically coupled to mitochondria (Fig. 10). In line with our data, mitochondrial “contamination” has been observed in fractionated SR vesicles of skeletal muscle. Interestingly, those data showed 2.8-fold greater mitochondrial presence (verified by F1F0-ATPase quantitative Western blotting) in the heavy SR comprised predominantly of terminal cisternae than in the light SR fraction (19). Thus, the terminal cisternae, the SR subdomains where the bulk of the RyR reside (32, 33), appeared to be preferred sites for SR-mitochondrial associations. In addition, Protasi and co-workers (14, 15) were able to visualize tethering structures between the terminal cisternae of the SR and mitochondria of skeletal muscle using conventional transmission electron microscopy as well as electron tomography.
We have successfully applied limited proteolysis by trypsin or proteinase K to disrupt the physical coupling between the ER and mitochondria and to show its role in the ER-mitochondrial Ca2+ transfer (8). Also, Saks et al. (16) were able to disrupt the local metabolic interplay between the sarcomere, the SERCA, and mitochondria (so called intra-cellular energetic units) by limited trypsinization of permeabilized cardiac and skeletal muscle cells, suggesting the participation of protein elements in that local spatial arrangement. However, in the present system of adherent RHM, trypsin started to trim integral membrane proteins of the SR (e.g. phospholamban; not shown) before an effect on the SR-mitochondrial Ca2+ coupling was detected. Thus, limited trypsinization could not be used to dissociate SR from the mitochondria in isolated RHM. Nevertheless, the SR-mitochondrial physical coupling resisted purification procedures that cause demolition of the cytoskeletal structures and was also present in highly purified mitochondria, suggesting that some membrane/membrane-associated proteins may form the bridge between the cardiac SR and mitochondria. Recently, Szabadkai et al. (34) have reported that the ER-mitochondrial links can be formed by the inositol 1,4,5-trisphosphate receptors and VDAC1 through the molecular chaperone grp75. A similar complex may exist in cardiac muscle, because the RyRs show considerable structural homology with the inositol 1,4,5-trisphosphate receptors, and the VDAC1 is also present in cardiac mitochondria. However, because most of the RyR2s reside on the far side of the terminal cisternae (35), it is likely that some other SR membrane proteins are also involved in the interorganellar linkage.
The present single-organelle calcium imaging experiments provided firm evidence that the RyR2 can transfer Ca2+ to the cardiac mitochondria through a local [Ca2+]c elevation. Although the majority of the RyR2 does not seem to directly face the mitochondria in the intact cardiac muscle, the RyR2s are sufficiently close (27–200 nm (9)) to the mitochondrial surface to expose the Ca2+ uptake sites to an estimated 10–20 μm [Ca2+]c during Ca2+ release (36). Regarding the molecular mechanism of the Ca2+ uptake by cardiac mitochondria, an interesting candidate is the mitochondrial mRyR1, recently described by Beutner, Sheu, and co-workers (22, 37, 38). The ruthenium derivative Ru360 has been reported highly specific to the MCU with no inhibitory effect on RyR2 in heart (21) or on RyR1 in skeletal muscle (39) (as opposed to ruthenium red that inhibits both MCU and RyR). Because Ru360 blocked the caffeine-stimulated [Ca2+]m signal almost as effectively as the mitochondrial uncoupler, major contribution of mRyR1 activity to that caffeine-induced [Ca2+]m signal was unlikely.
One might wonder whether the dynamics of [Ca2+] in the SR pools ([Ca2+]SR) associated with the mitochondria could also be monitored. Indeed, Shannon et al. (40) reported successful recordings of [Ca2+]SR increases in association with ATP-dependent Ca2+ accumulation or decreases evoked by caffeine in immobilized (in an agarose matrix) SR vesicles isolated from rabbit or rat heart ventricles using the low-affinity Ca2+ tracer fluo-5N. Unfortunately, in the present RHM system mitochondria readily accumulated fluo-5N, and the bright fluorescence derived from the mitochondria even in the presence of FCCP prevented us from distinguishing the SR-loaded dye (not shown).
The local Ca2+ communication between SR and mitochondria have been difficult to study until very recently, and therefore limited information is available about its physiological and possible pathological role(s) in the cardiac energy metabolism and excitation-contraction coupling (41). However, it has been discussed more and more that the SR-mitochondrial Ca2+ transfer is a significant regulatory factor of excitation-contraction and excitation-oxidative metabolic coupling (recently reviewed in Refs. 42–44). This direction is strengthened by our results that caffeine stimulation of RyR2-mediated Ca2+ release also evoked a rapid increase in the NAD(P)H levels in the pRHM mitochondria, underlying the metabolic relevance of the SR-mitochondrial complexes.
Acknowledgments
We are most grateful for the kind and tremendous help from Dr. Carmen Mannella in the form of daily advice and critical reviewing of the electron micrographs of the negatively stained mitochondrial samples. We also thank Dr. Theodore Taraschi and Timothy Schneider, the head and primary technician of the Departmental Electron microscopy Core, respectively, for support in using the electron microscope.
Footnotes
The abbreviations used are: ER, endoplasmic reticulum; SR, sarcoplasmic reticulum; RyR, ryanodine receptor; RHM, rat heart mitochondria; [Ca2+]m, mitochondrial matrix [Ca2+]; TMRE, tetramethyl rhodamine ethyl ester; CSQ, calsequestrin; SERCA, sarcoplasmic/endoplasmic reticulum Ca2+-ATPase; FCCP, carbonyl cyanide p-trifluoromethoxyphenylhydrazone; Tg, thapsigargin; MCU, mitochondrial Ca2+ uniporter; VDAC, voltage dependent anion channel.
This work was supported by an American Heart Association Grant SDG 0435236N. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1–S3.
REFERENCES
- 1.Di Lisa F, Gambassi G, Spurgeon H, Hansford RG. Cardiovasc Res. 1993;27:1840–1844. doi: 10.1093/cvr/27.10.1840. [DOI] [PubMed] [Google Scholar]
- 2.Hajnoczky G, Robb-Gaspers LD, Seitz MB, Thomas AP. Cell. 1995;82:415–424. doi: 10.1016/0092-8674(95)90430-1. [DOI] [PubMed] [Google Scholar]
- 3.Pralong WF, Hunyady L, Varnai P, Wollheim CB, Spat A. Proc Natl Acad Sci U S A. 1992;89:132–136. doi: 10.1073/pnas.89.1.132. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Csordas G, Thomas AP, Hajnoczky G. EMBO J. 1999;18:96–108. doi: 10.1093/emboj/18.1.96. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Rizzuto R, Pinton P, Carrington W, Fay FS, Fogarty KE, Lifshitz LM, Tuft RA, Pozzan T. Science. 1998;280:1763–1766. doi: 10.1126/science.280.5370.1763. [DOI] [PubMed] [Google Scholar]
- 6.Rizzuto R, Pozzan T. Physiol Rev. 2006;86:369–408. doi: 10.1152/physrev.00004.2005. [DOI] [PubMed] [Google Scholar]
- 7.Spat A, Szanda G, Csordas G, Hajnoczky G. Cell Calcium. 2008 doi: 10.1016/j.ceca.2007.11.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Csordas G, Renken C, Varnai P, Walter L, Weaver D, Buttle KF, Balla T, Mannella CA, Hajnoczky G. J Cell Biol. 2006;174:915–921. doi: 10.1083/jcb.200604016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Sharma VK, Ramesh V, Franzini-Armstrong C, Sheu SS. J Bioenerg Biomembr. 2000;32:97–104. doi: 10.1023/a:1005520714221. [DOI] [PubMed] [Google Scholar]
- 10.Szalai G, Csordas G, Hantash BM, Thomas AP, Hajnoczky G. J Biol Chem. 2000;275:15305–15313. doi: 10.1074/jbc.275.20.15305. [DOI] [PubMed] [Google Scholar]
- 11.Robert V, Massimino ML, Tosello V, Marsault R, Cantini M, Sorrentino V, Pozzan T. J Biol Chem. 2001;276:4647–4651. doi: 10.1074/jbc.M006337200. [DOI] [PubMed] [Google Scholar]
- 12.Rudolf R, Mongillo M, Magalhaes PJ, Pozzan T. J Cell Biol. 2004;166:527–536. doi: 10.1083/jcb.200403102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Shkryl VM, Shirokova N. J Biol Chem. 2006;281:1547–1554. doi: 10.1074/jbc.M505024200. [DOI] [PubMed] [Google Scholar]
- 14.Boncompagni S, Micaroni M, Beznoussenko G, Polishchuk RS, Protasi F. Biophys J. 2008;94:306a. [Google Scholar]
- 15.Boncompagni S, Protasi F. Biophys J. 2007;92:313a–314a. [Google Scholar]
- 16.Saks VA, Kaambre T, Sikk P, Eimre M, Orlova E, Paju K, Piirsoo A, Appaix F, Kay L, Regitz-Zagrosek V, Fleck E, Seppet E. Biochem J. 2001;356:643–657. doi: 10.1042/0264-6021:3560643. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Grynkiewicz G, Poenie M, Tsien RY. J Biol Chem. 1985;260:3440–3450. [PubMed] [Google Scholar]
- 18.Ganguly PK, Pierce GN, Dhalla KS, Dhalla NS. Am J Physiol. 1983;244:E528–E535. doi: 10.1152/ajpendo.1983.244.6.E528. [DOI] [PubMed] [Google Scholar]
- 19.Xia R, Webb JA, Gnall LL, Cutler K, Abramson JJ. Am J Physiol Cell Physiol. 2003;285:C215–C221. doi: 10.1152/ajpcell.00034.2002. [DOI] [PubMed] [Google Scholar]
- 20.Feher JJ. J Mol Cell Cardiol. 1998;30:1763–1772. doi: 10.1006/jmcc.1998.0740. [DOI] [PubMed] [Google Scholar]
- 21.Matlib MA, Zhou Z, Knight S, Ahmed S, Choi KM, Krause-Bauer J, Phillips R, Altschuld R, Katsube Y, Sperelakis N, Bers DM. J Biol Chem. 1998;273:10223–10231. doi: 10.1074/jbc.273.17.10223. [DOI] [PubMed] [Google Scholar]
- 22.Beutner G, Sharma VK, Giovannucci DR, Yule DI, Sheu SS. J Biol Chem. 2001;276:21482–21488. doi: 10.1074/jbc.M101486200. [DOI] [PubMed] [Google Scholar]
- 23.Csordas G, Hajnoczky G. J Biol Chem. 2003;278:42273–42282. doi: 10.1074/jbc.M305248200. [DOI] [PubMed] [Google Scholar]
- 24.Kroner H. Arch Biochem Biophys. 1986;251:525–535. doi: 10.1016/0003-9861(86)90360-7. [DOI] [PubMed] [Google Scholar]
- 25.Brandes R, Bers DM. Biophys J. 1996;71:1024–1035. doi: 10.1016/S0006-3495(96)79303-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Denton RM, McCormack JG, Edgell NJ. Biochem J. 1980;190:107–117. doi: 10.1042/bj1900107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Jouaville LS, Pinton P, Bastianutto C, Rutter GA, Rizzuto R. Proc Natl Acad Sci U S A. 1999;96:13807–13812. doi: 10.1073/pnas.96.24.13807. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Pacher P, Hajnoczky G. EMBO J. 2001;20:4107–4121. doi: 10.1093/emboj/20.15.4107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Szalai G, Krishnamurthy R, Hajnoczky G. EMBO J. 1999;18:6349–6361. doi: 10.1093/emboj/18.22.6349. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Demaurex N, Distelhorst C. Science. 2003;300:65–67. doi: 10.1126/science.1083628. [DOI] [PubMed] [Google Scholar]
- 31.Duchen MR, Leyssens A, Crompton M. J Cell Biol. 1998;142:975–988. doi: 10.1083/jcb.142.4.975. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Franzini-Armstrong C, Protasi F. Physiol Rev. 1997;77:699–729. doi: 10.1152/physrev.1997.77.3.699. [DOI] [PubMed] [Google Scholar]
- 33.Franzini-Armstrong C, Protasi F, Ramesh V. Biophys J. 1999;77:1528–1539. doi: 10.1016/S0006-3495(99)77000-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Szabadkai G, Bianchi K, Varnai P, De Stefani D, Wieckowski MR, Cavagna D, Nagy AI, Balla T, Rizzuto R. J Cell Biol. 2006;175:901–911. doi: 10.1083/jcb.200608073. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Franzini-Armstrong C. Physiol (Bethesda) 2007;22:261–268. doi: 10.1152/physiol.00017.2007. [DOI] [PubMed] [Google Scholar]
- 36.Neher E. Neuron. 1998;20:389–399. doi: 10.1016/s0896-6273(00)80983-6. [DOI] [PubMed] [Google Scholar]
- 37.Altschafl BA, Beutner G, Sharma VK, Sheu SS, Valdivia HH. Biochim Biophys Acta. 2007;1768:1784–1795. doi: 10.1016/j.bbamem.2007.04.011. [DOI] [PubMed] [Google Scholar]
- 38.Beutner G, Sharma VK, Lin L, Ryu SY, Dirksen RT, Sheu SS. Biochim Biophys Acta. 2005;1717:1–10. doi: 10.1016/j.bbamem.2005.09.016. [DOI] [PubMed] [Google Scholar]
- 39.Isaeva EV, Shirokova N. J Physiol. 2003;547:453–462. doi: 10.1113/jphysiol.2002.036129. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Shannon TR, Bers DM, Blatter LA, Niggli E. Cell Calcium. 2005;38:497–505. doi: 10.1016/j.ceca.2005.07.002. [DOI] [PubMed] [Google Scholar]
- 41.Csordas G, Thomas AP, Hajnoczky G. Trends Cardiovasc Med. 2001;11:269–275. doi: 10.1016/s1050-1738(01)00123-2. [DOI] [PubMed] [Google Scholar]
- 42.Dedkova EN, Blatter LA. Cell Calcium. 2008;44:77–91. doi: 10.1016/j.ceca.2007.11.002. [DOI] [PubMed] [Google Scholar]
- 43.Maack C, O’Rourke B. Basic Res Cardiol. 2007;102:369–392. doi: 10.1007/s00395-007-0666-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Brookes PS, Yoon Y, Robotham JL, Anders MW, Sheu SS. Am J Physiol. 2004;287:C817–C833. doi: 10.1152/ajpcell.00139.2004. [DOI] [PubMed] [Google Scholar]